{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:38:37Z","timestamp":1785425917530,"version":"3.56.0"},"reference-count":167,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400558"],"award-info":[{"award-number":["82400558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470504"],"award-info":[{"award-number":["82470504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82400558"],"award-info":[{"award-number":["82400558"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82470504"],"award-info":[{"award-number":["82470504"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L246053"],"award-info":[{"award-number":["L246053"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["QG26015"],"award-info":[{"award-number":["QG26015"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L246002"],"award-info":[{"award-number":["L246002"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High-Level Hospital Clinical Research Funding","award":["2026-PUMCH-A-055"],"award-info":[{"award-number":["2026-PUMCH-A-055"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["CIFMS 2021-I2M-1-016"],"award-info":[{"award-number":["CIFMS 2021-I2M-1-016"]}]},{"award":["CIFMS 2021-I2M-1-016"],"award-info":[{"award-number":["CIFMS 2021-I2M-1-016"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>The pathogenesis of cardiovascular diseases (CVDs) is intimately linked to cholesterol dysregulation. While high-density lipoprotein cholesterol (HDL-C) is classically considered cardioprotective, contemporary epidemiological evidence reveals a noncausal, often U-shaped, relationship with CVD risk. Static measurements of HDL-C obscure the structural and functional heterogeneity of circulating HDL particles. Under pathological stress, HDL undergoes extensive structural remodeling into dysfunctional HDL, thereby losing its vasculoprotective properties and instead mediating proatherogenic and proinflammatory responses. This review critically evaluates the biogenesis, maturation, and metabolic trajectory of HDL. By integrating recent advancements in proteomics and lipidomics, we map the intricate compositional shifts within HDL subpopulations and clarify the regulatory roles of HDL-associated microRNAs in intercellular communication. We investigate the specific drivers of HDL dysfunction, which is often exacerbated by comorbidities such as diabetes and chronic kidney disease. Furthermore, we outline the methodological transition from automated homogeneous HDL-C quantification to multidimensional profiling. Shifting the clinical focus from HDL quantity to functional quality resolves the HDL-C paradox, helping to drive the development of precision lipidology and targeted therapies to reverse HDL dysfunction in CVDs.<\/jats:p>","DOI":"10.3390\/antiox15070864","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:16:28Z","timestamp":1783689388000},"page":"864","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biology of HDL: From Structural Heterogeneity to Dysfunctional Remodeling in Cardiovascular Disease and Comorbidities"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5043-3725","authenticated-orcid":false,"given":"Yihang","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibo","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-9289","authenticated-orcid":false,"given":"Jianqiang","family":"Wu","sequence":"additional","affiliation":[{"name":"National Infrastructure for Translational Medicine, Institute of Clinical Medicine, Center for Biomarker Discovery and Validation, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/eurjpc\/zwae281","article-title":"Global burden of cardiovascular diseases: Projections from 2025 to 2050","volume":"32","author":"Chong","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_3","first-page":"9","article-title":"Studies on the lipid-protein relationship in normal and pathological sera and the effect of heparin on serum lipoproteins","volume":"5","author":"Nikkila","year":"1953","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.22.6.1091","article-title":"Serum cholesterol and relative body weight of coronary patients in different populations","volume":"22","author":"Keys","year":"1960","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0002-9343(51)90183-0","article-title":"Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions","volume":"11","author":"Barr","year":"1951","journal-title":"Am. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.7326\/0003-4819-49-4-732","article-title":"Serum cholesterol, electrophoretic lipid pattern, diet and coronary artery disease: A study in coronary patients and in healthy men of different origin and occupations in Israel","volume":"49","author":"Brunner","year":"1958","journal-title":"Ann. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.0954-6820.1960.tb03562.x","article-title":"Serum lipids in men with myocardial infarction","volume":"167","author":"Carlson","year":"1960","journal-title":"Acta Med. Scand."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1172\/JCI103358","article-title":"A study of serum lipoproteins in normal and atherosclerotic patients by paper electrophoretic techniques","volume":"35","author":"Durrum","year":"1956","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM197602052940601","article-title":"Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men","volume":"294","author":"Rhoads","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2174\/1570161115666171116164612","article-title":"High-density Lipoprotein (HDL) Dysfunction and the Future of HDL","volume":"16","author":"Ertek","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155817","DOI":"10.1016\/j.metabol.2024.155817","article-title":"Nonlinear relationship between high-density lipoprotein cholesterol and cardiovascular disease: An observational and Mendelian randomization analysis","volume":"154","author":"Chen","year":"2024","journal-title":"Metabolism"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/STROKEAHA.121.034393","article-title":"U-Shaped Relationship of High-Density Lipoprotein Cholesterol and Incidence of Total, Ischemic and Hemorrhagic Stroke: A Prospective Cohort Study","volume":"53","author":"Li","year":"2022","journal-title":"Stroke"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/HYPERTENSIONAHA.122.19912","article-title":"High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients","volume":"79","author":"Trimarco","year":"2022","journal-title":"Hypertension"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14789450.2019.1650645","article-title":"Deepening our understanding of HDL proteome","volume":"16","author":"Ronsein","year":"2019","journal-title":"Expert Rev. Proteom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-2275(20)41536-6","article-title":"The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function","volume":"33","author":"Segrest","year":"1992","journal-title":"J. Lipid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"22249","DOI":"10.1074\/jbc.R700014200","article-title":"The structure of apolipoprotein A-I in high density lipoproteins","volume":"282","author":"Davidson","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Casula, M., Colpani, O., Xie, S., Catapano, A.L., and Baragetti, A. (2021). HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role. Cells, 10.","DOI":"10.3390\/cells10081869"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2174\/138945011795378522","article-title":"ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: Important targets for the treatment of atherosclerosis","volume":"12","author":"Ye","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0003319719854609","article-title":"\u03a4he Antioxidant Function of HDL in Atherosclerosis","volume":"71","author":"Xepapadaki","year":"2020","journal-title":"Angiology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCRESAHA.117.312317","article-title":"AMPK\u03b12 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation","volume":"122","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Diarte-A\u00f1azco, E.M.G., M\u00e9ndez-Lara, K.A., P\u00e9rez, A., Alonso, N., Blanco-Vaca, F., and Julve, J. (2019). Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246273"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bph.12174","article-title":"HDL and endothelial protection","volume":"169","author":"Diallo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1074\/jbc.M211394200","article-title":"High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases","volume":"278","author":"Mineo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/imm.12638","article-title":"High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation","volume":"149","author":"Thacker","year":"2016","journal-title":"Immunology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"Labzin","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.111.061986","article-title":"Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions","volume":"125","author":"Robbins","year":"2012","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/CIRCULATIONAHA.113.000962","article-title":"Translation of high-density lipoprotein function into clinical practice: Current prospects and future challenges","volume":"128","author":"Rosenson","year":"2013","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.lfs.2011.10.018","article-title":"The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins","volume":"90","author":"Loued","year":"2012","journal-title":"Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"104528","DOI":"10.1016\/j.cellimm.2022.104528","article-title":"The lipid ties of \u03b11-antitrypsin: Structural and functional aspects","volume":"375","author":"Segal","year":"2022","journal-title":"Cell. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2016.11.015","article-title":"High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis","volume":"259","author":"Gordon","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.0000070589.61860.A9","article-title":"L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease","volume":"107","author":"Ou","year":"2003","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.V89.7.2429","article-title":"Apoptotic vascular endothelial cells become procoagulant","volume":"89","author":"Bombeli","year":"1997","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/hh1001.090571","article-title":"Current perspective on the role of apoptosis in atherothrombotic disease","volume":"88","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/hc2401.092816","article-title":"Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease","volume":"103","author":"Vasa","year":"2001","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.RES.0000124302.20396.B7","article-title":"Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt\/endothelial nitric oxide synthase","volume":"94","author":"Viswambharan","year":"2004","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI110385","article-title":"Deficiency of protein C in congenital thrombotic disease","volume":"68","author":"Griffin","year":"1981","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/blood.V97.7.1907","article-title":"Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway","volume":"97","author":"Deguchi","year":"2001","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1074\/jbc.M110252200","article-title":"Neutral glycosphingolipid-dependent inactivation of coagulation factor Va by activated protein C and protein S","volume":"277","author":"Deguchi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1074\/jbc.M302531200","article-title":"Sphingolipids as bioactive regulators of thrombin generation","volume":"279","author":"Deguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1038\/s41467-018-05806-0","article-title":"Apolipoprotein A-IV binds \u03b1IIb\u03b23 integrin and inhibits thrombosis","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0022-2275(20)38312-7","article-title":"Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation","volume":"30","author":"Desai","year":"1989","journal-title":"J. Lipid Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"296417","DOI":"10.1155\/2015\/296417","article-title":"Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics","volume":"2015","author":"Salazar","year":"2015","journal-title":"Cholesterol"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/ATVBAHA.118.311607","article-title":"Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies","volume":"38","author":"Furtado","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/ATVBAHA.123.319742","article-title":"Understanding HDL Metabolism and Biology Through In Vivo Tracer Kinetics","volume":"44","author":"Andraski","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1042\/CS20258040","article-title":"HDL protein composition differs between young white European and South Asian men before and after weight gain","volume":"139","author":"Beazer","year":"2025","journal-title":"Clin. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"118565","DOI":"10.1016\/j.atherosclerosis.2024.118565","article-title":"Relationships between HDL subpopulation proteome and HDL function in overweight\/obese people with and without coronary heart disease","volume":"397","author":"Vaisar","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14789450.2018.1402680","article-title":"Quantifying HDL proteins by mass spectrometry: How many proteins are there and what are their functions?","volume":"15","author":"Shao","year":"2018","journal-title":"Expert Rev. Proteom."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1681\/ASN.2015101121","article-title":"Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort","volume":"27","author":"Kozlitina","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: Role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/ATVBAHA.124.320851","article-title":"Interactions Between HDL and CD4+ T Cells: A Novel Understanding of HDL Anti-Inflammatory Properties","volume":"44","author":"Atehortua","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","article-title":"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice","volume":"106","author":"Tward","year":"2002","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00018-020-03715-4","article-title":"Integrating lipidomics and genomics: Emerging tools to understand cardiovascular diseases","volume":"78","author":"Tabassum","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1021\/acs.jproteome.7b00236","article-title":"Comprehensive Lipoprotein Characterization Using Lipidomics Analysis of Human Plasma","volume":"16","author":"Christinat","year":"2017","journal-title":"J. Proteome Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.clinbiochem.2014.11.017","article-title":"HDL particle number measured on the Vantera\u00ae, the first clinical NMR analyzer","volume":"48","author":"Matyus","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.atherosclerosis.2015.06.040","article-title":"Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration","volume":"241","author":"Denimal","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1194\/jlr.P068585","article-title":"Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia","volume":"57","author":"Orsoni","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1021\/acs.jproteome.6b00975","article-title":"NMR-Based Lipid Profiling of High Density Lipoprotein Particles in Healthy Subjects with Low, Normal, and Elevated HDL-Cholesterol","volume":"16","author":"Kostara","year":"2017","journal-title":"J. Proteome Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/hq0302.105374","article-title":"Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation","volume":"22","author":"Rashid","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/cvp070","article-title":"Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection","volume":"82","author":"Sattler","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000362993","article-title":"HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis","volume":"34","author":"Sattler","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1194\/jlr.R035964","article-title":"HDL and cholesterol: Life after the divorce?","volume":"55","author":"Vickers","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MOL.0b013e328350a425","article-title":"Lipid-based carriers of microRNAs and intercellular communication","volume":"23","author":"Vickers","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/ATVBAHA.112.300139","article-title":"Intercellular transport of microRNAs","volume":"33","author":"Boon","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/ncomms4292","article-title":"HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells","volume":"5","author":"Tabet","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11883-021-00930-7","article-title":"HDL-small RNA Export, Transport, and Functional Delivery in Atherosclerosis","volume":"23","author":"Vickers","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"114623","DOI":"10.1016\/j.biopha.2023.114623","article-title":"Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile","volume":"162","author":"Belmonte","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41419-020-03263-6","article-title":"LncRNA kcnq1ot1 promotes lipid accumulation and accelerates atherosclerosis via functioning as a ceRNA through the miR-452-3p\/HDAC3\/ABCA1 axis","volume":"11","author":"Yu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3892\/ijmm.2025.5621","article-title":"Epigenetic-ncRNA crosstalk in atherosclerosis: Mechanisms, disease progression and therapeutic potential (Review)","volume":"56","author":"Zhu","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-511X-11-54","article-title":"High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes","volume":"11","author":"Tian","year":"2012","journal-title":"Lipids Health Dis."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Cho, K.H., Kim, J.R., Lee, I.C., and Kwon, H.J. (2021). Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity. Antioxidants, 10.","DOI":"10.3390\/antiox10020209"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11883-025-01378-9","article-title":"HDL in Abdominal Aortic Aneurysm: Mechanistic Insight and Therapeutic Potential","volume":"28","author":"Catalano","year":"2026","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1074\/jbc.M407019200","article-title":"Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages","volume":"280","author":"Zheng","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1074\/jbc.RA118.005663","article-title":"Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule","volume":"294","author":"Witkowski","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12944-023-01847-7","article-title":"Adipose tissue dysfunction serum markers are associated with high density lipoprotein size and glycation in the early stages of type 2 diabetes","volume":"22","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5551\/jat.55699","article-title":"Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate","volume":"28","author":"Kobayashi","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_98","first-page":"442","article-title":"Differential impact of glycation on apolipoprotein A-I of high-density lipoprotein: A review","volume":"33","author":"Maarfi","year":"2023","journal-title":"Glycobiology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.dsx.2022.102592","article-title":"Association of hemoglobin glycation index with cardiovascular risk factors in non-diabetic adults: A cross-sectional study","volume":"16","author":"Rajendran","year":"2022","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1089\/ars.2010.3640","article-title":"Protein carbamylation renders high-density lipoprotein dysfunctional","volume":"14","author":"Holzer","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/ars.2011.4403","article-title":"Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: Novel pathways generating dysfunctional high-density lipoprotein","volume":"17","author":"Holzer","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"F511","DOI":"10.1152\/ajprenal.00508.2015","article-title":"Increased carbamylation level of HDL in end-stage renal disease: Carbamylated-HDL attenuated endothelial cell function","volume":"310","author":"Sun","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1074\/jbc.RA117.001099","article-title":"Modification by isolevuglandins, highly reactive \u03b3-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function","volume":"293","author":"Yermalitsky","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"18473","DOI":"10.1074\/jbc.M110.118182","article-title":"Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway","volume":"285","author":"Shao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1152\/physrev.00003.2018","article-title":"Homocysteine Modification in Protein Structure\/Function and Human Disease","volume":"99","author":"Jakubowski","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1139\/cjpp-2014-0491","article-title":"Hyperhomocysteinemia: A missing link to dysfunctional HDL via paraoxanase-1","volume":"93","author":"Givvimani","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/S0022-2275(20)37469-1","article-title":"HDL content and composition in acute phase response in three species: Triglyceride enrichment of HDL a factor in its decrease","volume":"37","author":"Cabana","year":"1996","journal-title":"J. Lipid Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/CIRCULATIONAHA.105.591743","article-title":"Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells","volume":"113","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Hama","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1525-139X.2009.00578.x","article-title":"PROGRESS IN UREMIC TOXIN RESEARCH: Asymmetric dimethylarginine and symmetric dimethylarginine: Axis of evil or useful alliance?","volume":"22","author":"Kielstein","year":"2009","journal-title":"Semin. Dial."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014A meta-analysis","volume":"21","author":"Kielstein","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00338-3","article-title":"Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases","volume":"336","author":"Fleck","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.kint.2019.10.017","article-title":"Symmetric dimethylarginine in dysfunctional high-density lipoprotein mediates endothelial glycocalyx breakdown in chronic kidney disease","volume":"97","author":"Hesse","year":"2020","journal-title":"Kidney Int."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/biof.1800","article-title":"Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high-density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus","volume":"48","author":"Sanda","year":"2022","journal-title":"Biofactors"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/jc.2017-01551","article-title":"Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes","volume":"103","author":"Kashyap","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Rysz, J., Gluba-Brz\u00f3zka, A., Rysz-G\u00f3rzy\u0144ska, M., and Franczyk, B. (2020). The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020601"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.M059089","article-title":"Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity","volume":"56","author":"Vaisar","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Adorni, M.P., Palumbo, M., Marchi, C., Zimetti, F., Ossoli, A., Turri, M., Bernini, F., Hollan, I., Mol\u00e1\u010dek, J., and Treska, V. (2022). HDL metabolism and functions impacting on cell cholesterol homeostasis are specifically altered in patients with abdominal aortic aneurysm. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.935241"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/bbrc.2000.2649","article-title":"Enhanced macrophage uptake of elastase-modified high-density lipoproteins","volume":"271","author":"Pirillo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1096\/fj.08-127928","article-title":"HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property","volume":"23","author":"Houard","year":"2009","journal-title":"FASEB J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.atherosclerosis.2014.06.007","article-title":"Evidence for an exclusive association of matrix metalloproteinase-9 with dysfunctional high-density lipoprotein: A novel finding","volume":"236","author":"Sini","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12967-020-02623-2","article-title":"Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: Carbamylated high-density lipoprotein of patients promotes monocyte adhesion","volume":"18","author":"Chen","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1038\/nutd.2014.31","article-title":"Arginine-directed glycation and decreased HDL plasma concentration and functionality","volume":"4","author":"Godfrey","year":"2014","journal-title":"Nutr. Diabetes"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Carrio, J., Lindholt, J.S., Canyelles, M., Mart\u00ednez-L\u00f3pez, D., Tondo, M., Blanco-Colio, L.M., Michel, J.B., Escol\u00e0-Gil, J.C., Su\u00e1rez, A., and Mart\u00edn-Ventura, J.L. (2019). IgG Anti-High Density Lipoprotein Antibodies Are Elevated in Abdominal Aortic Aneurysm and Associated with Lipid Profile and Clinical Features. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010067"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2021.08.004","article-title":"Malondialdehyde-modified HDL particles elicit a specific IgG response in abdominal aortic aneurysm","volume":"174","author":"Lindholt","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0022-2275(20)33462-3","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3","volume":"41","author":"Navab","year":"2000","journal-title":"J. Lipid Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment","volume":"108","author":"Ansell","year":"2003","journal-title":"Circulation"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nat. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCRESAHA.114.302805","article-title":"Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome","volume":"114","author":"Rosenson","year":"2014","journal-title":"Circ. Res."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Bobek, J.M., Stuttgen, G.M., and Sahoo, D. (2024). A comprehensive analysis of the role of native and modified HDL in ER stress in primary macrophages. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1448607"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41392-023-01558-6","article-title":"High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA","volume":"8","author":"Mo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12265-023-10447-w","article-title":"High-Density Lipoprotein: A Molecule-Modulating Angiogenesis","volume":"17","author":"Lu","year":"2024","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Liao, Y.H., Wu, S., Ko, Y.L., and Teng, M.S. (2025). Effects of HDL Structure and Function in Peripheral Artery Disease. Biomolecules, 15.","DOI":"10.3390\/biom15101419"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/ATVBAHA.120.315828","article-title":"Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease","volume":"41","author":"Kou","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.dsx.2016.08.029","article-title":"Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and \u03b2-cell function in men with T2DM","volume":"11","author":"Hermans","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Sergi, D., Zauli, E., Tisato, V., Secchiero, P., Zauli, G., and Cervellati, C. (2023). Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054403"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e131491","DOI":"10.1172\/jci.insight.131491","article-title":"Structure-function relationships of HDL in diabetes and coronary heart disease","volume":"5","author":"Cardner","year":"2020","journal-title":"JCI Insight"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db09-1114","article-title":"Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women","volume":"59","author":"Mora","year":"2010","journal-title":"Diabetes"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","article-title":"Pathophysiology of diabetic dyslipidaemia: Where are we?","volume":"58","year":"2015","journal-title":"Diabetologia"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Feng, J., Wang, Y., Li, W., Zhao, Y., Liu, Y., Yao, X., Liu, S., Yu, P., and Li, R. (2022). High levels of oxidized fatty acids in HDL impair the antioxidant function of HDL in patients with diabetes. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.993193"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2013111212","article-title":"HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype","volume":"25","author":"Shroff","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","article-title":"Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2","volume":"38","author":"Speer","year":"2013","journal-title":"Immunity"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"Zewinger","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbacli.2015.01.005","article-title":"High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk","volume":"3","author":"Hafiane","year":"2015","journal-title":"BBA Clin."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1373\/clinchem.2009.142810","article-title":"Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures","volume":"56","author":"Miller","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Emeasoba, E.U., Ibeson, E., Nwosu, I., Montemarano, N., Shani, J., and Shetty, V.S. (2022). Clinical Relevance of Nuclear Magnetic Resonance LipoProfile. Front. Nucl. Med., 2.","DOI":"10.3389\/fnume.2022.960522"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jmsacl.2021.12.005","article-title":"Lipid analysis by ion mobility spectrometry combined with mass spectrometry: A brief update with a perspective on applications in the clinical laboratory","volume":"23","author":"Dubland","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40256-015-0146-z","article-title":"Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial","volume":"16","author":"Nicholls","year":"2016","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1009744","article-title":"Safety of anacetrapib in patients with or at high risk for coronary heart disease","volume":"363","author":"Cannon","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-2275(20)32113-1","article-title":"Cell cholesterol efflux: Integration of old and new observations provides new insights","volume":"40","author":"Rothblat","year":"1999","journal-title":"J. Lipid Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41598-023-28953-x","article-title":"Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk","volume":"13","author":"Murakami","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.D018937","article-title":"A biochemical fluorometric method for assessing the oxidative properties of HDL","volume":"52","author":"Kelesidis","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"945","DOI":"10.5551\/jat.ED111","article-title":"A Novel Indicator for HDL Functionality","volume":"26","author":"Irino","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Estrada-Luna, D., Ortiz-Rodriguez, M.A., Medina-Brise\u00f1o, L., Carre\u00f3n-Torres, E., Izquierdo-Vega, J.A., Sharma, A., Cancino-D\u00edaz, J.C., P\u00e9rez-M\u00e9ndez, O., Belefant-Miller, H., and Betanzos-Cabrera, G. (2018). Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease. Molecules, 23.","DOI":"10.3390\/molecules23112730"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311978","article-title":"Trials and Tribulations of CETP Inhibitors","volume":"122","author":"Tall","year":"2018","journal-title":"Circ. Res."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Giammanco, A., Noto, D., Barbagallo, C.M., Nardi, E., Caldarella, R., Ciaccio, M., Averna, M.R., and Cefal\u00f9, A.B. (2021). Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases. Life, 11.","DOI":"10.3390\/life11060581"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.116.025687","article-title":"Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)","volume":"134","author":"Korjian","year":"2016","journal-title":"Circulation"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.10.018","article-title":"CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice","volume":"232","author":"Tardy","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCRESAHA.114.301804","article-title":"Novel therapies focused on the high-density lipoprotein particle","volume":"114","author":"Brewer","year":"2014","journal-title":"Circ. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2020.3308","article-title":"Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients with Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial","volume":"323","author":"Ray","year":"2020","journal-title":"JAMA"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Ouyang, F.W., Chiang, H.H., Hsu, W.L., Tsai, M.H., Huang, C.Y., Remaley, A.T., Akyol, O., and Chen, C.H. (2025). Dysfunctional high-density lipoprotein: An updated review. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1713387"},{"key":"ref_165","first-page":"106951","article-title":"GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease","volume":"165","author":"Genua","year":"2025","journal-title":"Med. Clin."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Lui, D.T.W., Li, L., Liu, X., Xiong, X., Tang, E.H.M., Lee, C.H., Woo, Y.C., Lang, B.H.H., Wong, C.K.H., and Tan, K.C.B. (2024). The association of HDL-cholesterol levels with incident major adverse cardiovascular events and mortality in 0.6 million individuals with type 2 diabetes: A population-based retrospective cohort study. BMC Med., 22.","DOI":"10.1186\/s12916-024-03810-4"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"111900","DOI":"10.1016\/j.biopha.2021.111900","article-title":"High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis","volume":"141","author":"Kudinov","year":"2021","journal-title":"Biomed. Pharmacother."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/7\/864\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:30:58Z","timestamp":1783690258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/7\/864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":167,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antiox15070864"],"URL":"https:\/\/doi.org\/10.3390\/antiox15070864","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}